Background And Aims:
Disentangling the putative impact of cannabis on brain morphology from other comorbid substance use is critical. After controlling for the effects of nicotine, alcohol and multi-substance use, this study aimed to determine whether frequent cannabis use is associated with significantly smaller subcortical grey matter volumes.
Design:
Exploratory analyses using mixed linear models, one per region of interest (ROI), were performed whereby individual differences in volume (outcome) at seven subcortical ROIs were regressed onto cannabis and comorbid substance use (predictors).
Setting:
Two large population-based twin samples from the United States and Australia.
Participants:
A total of 622 young Australian adults [66% female; μ = 25.9, standard deviation SD) = 3.6] and 474 middle-aged US males (μ = 56.1 ) of predominately Anglo-Saxon ancestry with complete substance use and imaging data. Subjects with a history of stroke or traumatic brain injury were excluded.
Measurements:
Magnetic resonance imaging (MRI) and volumetric segmentation methods were used to estimate volume in seven subcortical ROIs: thalamus, caudate nucleus, putamen, pallidum, hippocampus, amygdala and nucleus accumbens. Substance use measurements included maximum nicotine and alcohol use, total life-time multi-substance use, maximum cannabis use in the young adults and regular cannabis use in the middle-aged males.
Findings:
After correcting for multiple testing (P = 0.007), cannabis use was unrelated to any subcortical ROI. However, maximum nicotine use was associated with significantly smaller thalamus volumes in middle-aged males.
Conclusions:
In exploratory analyses based on young adult and middle-aged samples, normal variation in cannabis use is unrelated statistically to individual differences in brain morphology as measured by subcortical volume.
Citing Articles
Association Between Cannabis Use and Brain Structures: A Mendelian Randomization Study.
Li J, Yin Z, Yu Z, Li J, Yang L
Cureus. 2024; 16(8):e65922.
PMID: 39221390
PMC: 11365007.
DOI: 10.7759/cureus.65922.
Testing the consequences of alcohol, cannabis, and nicotine use on hippocampal volume: a quasi-experimental cotwin control analysis of young adult twins.
Harper J, Wilson S, Bair J, Hunt R, Thomas K, Malone S
Psychol Med. 2023; 53(6):2671-2681.
PMID: 37310301
PMC: 10123841.
DOI: 10.1017/S0033291721004682.
Chronic tobacco smoking, impaired reward-based decision-making, and role of insular cortex: A comparison between early-onset smokers and late-onset smokers.
Conti A, Baldacchino A
Front Psychiatry. 2022; 13:939707.
PMID: 36090372
PMC: 9459116.
DOI: 10.3389/fpsyt.2022.939707.
Diminished Structural Brain Integrity in Long-term Cannabis Users Reflects a History of Polysubstance Use.
Knodt A, Meier M, Ambler A, Gehred M, Harrington H, Ireland D
Biol Psychiatry. 2022; 92(11):861-870.
PMID: 36008158
PMC: 9637748.
DOI: 10.1016/j.biopsych.2022.06.018.
Neuroanatomical Correlates of Impulsive Choices and Risky Decision Making in Young Chronic Tobacco Smokers: A Voxel-Based Morphometry Study.
Conti A, Baldacchino A
Front Psychiatry. 2021; 12:708925.
PMID: 34526922
PMC: 8435625.
DOI: 10.3389/fpsyt.2021.708925.
Shared Genetic Etiology between Cortical Brain Morphology and Tobacco, Alcohol, and Cannabis Use.
Rabinowitz J, Campos A, Ong J, Garcia-Marin L, Alcauter S, Mitchell B
Cereb Cortex. 2021; 32(4):796-807.
PMID: 34379727
PMC: 8841600.
DOI: 10.1093/cercor/bhab243.
Associations of cannabis use disorder with cognition, brain structure, and brain function in African Americans.
Koenis M, Durnez J, Rodrigue A, Mathias S, Alexander-Bloch A, Barrett J
Hum Brain Mapp. 2020; 42(6):1727-1741.
PMID: 33340172
PMC: 7978126.
DOI: 10.1002/hbm.25324.
A unified framework for association and prediction from vertex-wise grey-matter structure.
Couvy-Duchesne B, Strike L, Zhang F, Holtz Y, Zheng Z, Kemper K
Hum Brain Mapp. 2020; 41(14):4062-4076.
PMID: 32687259
PMC: 7469763.
DOI: 10.1002/hbm.25109.
Self-reported cognition and marijuana use in older adults: Results from the national epidemiologic survey on alcohol and related conditions-III.
Benitez A, Lauzon S, Nietert P, McRae-Clark A, Sherman B
Addict Behav. 2020; 108:106437.
PMID: 32330763
PMC: 7282995.
DOI: 10.1016/j.addbeh.2020.106437.
Recent cannabis use is associated with smaller hippocampus volume: High-resolution segmentation of structural subfields in a large non-clinical sample.
Owens M, Sweet L, MacKillop J
Addict Biol. 2020; 26(1):e12874.
PMID: 31991525
PMC: 9187039.
DOI: 10.1111/adb.12874.
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.
Burggren A, Shirazi A, Ginder N, London E
Am J Drug Alcohol Abuse. 2019; 45(6):563-579.
PMID: 31365275
PMC: 7027431.
DOI: 10.1080/00952990.2019.1634086.
Association of antidepressants with brain morphology in early stages of psychosis: an imaging genomics approach.
Bykowsky O, Harrisberger F, Schmidt A, Smieskova R, Hauke D, Egloff L
Sci Rep. 2019; 9(1):8516.
PMID: 31186482
PMC: 6560086.
DOI: 10.1038/s41598-019-44903-y.
Preliminary results from a pilot study examining brain structure in older adult cannabis users and nonusers.
Thayer R, YorkWilliams S, Hutchison K, Bryan A
Psychiatry Res Neuroimaging. 2019; 285:58-63.
PMID: 30785022
PMC: 6450383.
DOI: 10.1016/j.pscychresns.2019.02.001.
Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.
Orr C, Spechler P, Cao Z, Albaugh M, Chaarani B, Mackey S
J Neurosci. 2019; 39(10):1817-1827.
PMID: 30643026
PMC: 6407302.
DOI: 10.1523/JNEUROSCI.3375-17.2018.